← Back to headlines
Jefferies Maintains 'Buy' Rating on Eli Lilly and Company (LLY)
Jefferies has reiterated its 'Buy' rating for pharmaceutical giant Eli Lilly and Company (LLY).
29 Mar, 20:15 — 29 Mar, 20:15
Sources
Showing 1 of 1 sources
Related Stories
New Single-Dose Treatment for Sleeping Sickness Aims for 2030 Elimination
22m ago
European Foreign Ministers Appeal to Israel Over Planned Death Penalty Expansion
28m ago
Is LeMaitre Vascular, Inc. (LMAT) A Good Stock To Buy Now?
45m ago
Is Bristol-Myers Squibb Company (BMY) A Good Stock To Buy Now?
48m ago